Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer.
Front Pharmacol
; 14: 1130937, 2023.
Article
in En
| MEDLINE
| ID: mdl-37033636
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Front Pharmacol
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Switzerland